The emerging role of epigenetics in stroke: III. Neural stem cell biology and regenerative medicine

Archives of Neurology

Volumn 68, Issue 3, 2011, Pages 294-302

  Qureshi, Irfan A ^a   Mehler, Mark F ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; DNA METHYLTRANSFERASE INHIBITOR; HISTONE DEACETYLASE INHIBITOR; LIPOSOME; NANOCARRIER; NANOPARTICLE; TRICHOSTATIN A;

BRAIN ISCHEMIA; DRUG EFFECT; EMBRYONIC STEM CELL; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NANOTECHNOLOGY; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; RNA INTERFERENCE; STROKE;

EPIGENOMICS; HUMANS; NERVE REGENERATION; NEURAL STEM CELLS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STROKE;

EID: 79952596383     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.6     Document Type: Review

References (65)

1. Lloyd-Jones D, Adams R, Carnethon M, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):480-486.
2. Ginsberg MD. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke. 2009;40(3)(suppl):S111-S114.
3. Burns TC, Verfaillie CM, Low WC. Stem cells for ischemic brain injury: a critical review. J Comp Neurol. 2009;515(1):125-144.
4. Farin A, Liu CY, Langmoen IA, Apuzzo ML. Biological restoration of central nervous system architecture and function, part 3: stem cell- and cell-based applications and realities in the biological management of central nervous system disorders: traumatic, vascular, and epilepsy disorders. Neurosurgery. 2009;65(5):831-859, discussion 859.
5. Mattick JS, Amaral PP, Dinger ME, Mercer TR, Mehler MF. RNA regulation of epigenetic processes. Bioessays. 2009;31(1):51-59.
6. Mehler MF, Mattick JS. Non-coding RNAs in the nervous system. J Physiol. 2006;575(pt 2):333-341. (Pubitemid 44270162)
7. Mercer TR, Dinger ME, Mariani J, Kosik KS, Mehler MF, Mattick JS. Noncoding RNAs in long-term memory formation. Neuroscientist. 2008;14(5):434-445.
8. Mehler MF, Mattick JS. Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol Rev. 2007;87(3):799-823. (Pubitemid 47084671)
9. Mehler MF. Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol. 2008;86(4):305-341.
10. Conti L, Cattaneo E. Neural stem cell systems: physiological players or in vitro entities? Nat Rev Neurosci. 2010;11(3):176-187.
11. Borlongan CV. Cell therapy for stroke: remaining issues to address before embarking on clinical trials. Stroke. 2009;40(3)(suppl):S146-S148.
12. Qu Q, Shi Y. Neural stem cells in the developing and adult brains. J Cell Physiol. 2009;221(1):5-9.
13. Bliss TM, Andres RH, Steinberg GK. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis. 2010;37(2):275-283.
14. Erdö F, Bührle C, Blunk J, et al. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab. 2003;23(7):780-785. (Pubitemid 36818686)
15. Hara K, Yasuhara T, Maki M, et al. Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Prog Neurobiol. 2008;85(3):318-334.
16. Tani J, Umbas R. Recent progressions in stem cell research: breakthroughs achieved and challenges faced. Acta Med Indones. 2009;41(1):30-35.
17. Locatelli F, Bersano A, Ballabio E, et al. Stem cell therapy in stroke. Cell Mol Life Sci. 2009;66(5):757-772.
18. Chopp M, Steinberg GK, Kondziolka D, et al. Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant. 2009;18(7):691-693.
19. Nakayama D, Matsuyama T, Ishibashi-Ueda H, et al. Injury-induced neural stem/ progenitor cells in post-stroke human cerebral cortex. Eur J Neurosci. 2010;31(1):90-98.
20. Ohab JJ, Fleming S, Blesch A, Carmichael ST. A neurovascular niche for neurogenesis after stroke. J Neurosci. 2006;26(50):13007-13016. (Pubitemid 44954619)
21. Yamashita T, Ninomiya M, Hernández Acosta P, et al. Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J Neurosci. 2006;26(24):6627-6636. (Pubitemid 44318344)
22. Thored P, Arvidsson A, Cacci E, et al. Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells. 2006;24(3):739-747. (Pubitemid 44464779)
23. Wang Y-Q, Guo X, Qiu M-H, Feng X-Y, Sun F-Y. VEGF overexpression enhances striatal neurogenesis in brain of adult rat after a transient middle cerebral artery occlusion. J Neurosci Res. 2007;85(1):73-82. (Pubitemid 46079798)
24. Leker RR. Fate and manipulations of endogenous neural stem cells following brain ischemia. Expert Opin Biol Ther. 2009;9(9):1117-1125.
25. Nakatomi H, Kuriu T, Okabe S, et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell. 2002;110(4):429-441. (Pubitemid 35232287)
26. Tavazoie M, Van der Veken L, Silva-Vargas V, et al. A specialized vascular niche for adult neural stem cells. Cell Stem Cell. 2008;3(3):279-288.
27. Guillemot F. Cell fate specification in the mammalian telencephalon. Prog Neurobiol. 2007;83(1):37-52. (Pubitemid 47243778)
28. Abrajano JJ, Qureshi IA, Gokhan S, Zheng D, Bergman A, Mehler MF. REST and CoREST modulate neuronal subtype specification, maturation and maintenance. PLoS One. 2009;4(12):e7936. doi:10.1371/journal.pone.0007936. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0007936. Accessed March 1, 2010.
29. Abrajano JJ, Qureshi IA, Gokhan S, Zheng D, Bergman A, Mehler MF. Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation. PLoS One. 2009;4(11):e7665. doi:10.1371 /journal.pone.0007665. http://www.plosone.org/article/info%3Adoi%2F10.1371 %2Fjournal.pone.0007665. Accessed March 1, 2010.
30. Qureshi IA, Mehler MF. Regulation of non-coding RNA networks in the nervous system - what's the REST of the story? Neurosci Lett. 2009;466(2):73-80.
31. Sanosaka T, Namihira M, Nakashima K. Epigenetic mechanisms in sequential differentiation of neural stem cells. Epigenetics. 2009;4(2):89-92.
32. Singh RP, Shiue K, Schomberg D, Zhou FC. Cellular epigenetic modifications of neural stem cell differentiation. Cell Transplant. 2009;18(10):1197-1211.
33. MacDonald JL, Roskams AJ. Epigenetic regulation of nervous system development by DNA methylation and histone deacetylation. Prog Neurobiol. 2009;88(3):170-183.
34. Hatada I, Namihira M, Morita S, Kimura M, Horii T, Nakashima K. Astrocyte-specific genes are generally demethylated in neural precursor cells prior to astrocytic differentiation. PLoS One. 2008;3(9):e3189. doi:10.1371/journal.pone .0003189. Accessed March 1, 2010.
35. Ma DK, Jang M-H, Guo JU, et al. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science. 2009;323(5917):1074-1077.
36. Williams RR, Azuara V, Perry P, et al. Neural induction promotes large-scale chromatin reorganisation of the Mash1 locus. J Cell Sci. 2006;119(pt 1):132-140. (Pubitemid 43169306)
37. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 2003;425(6961):962-967. (Pubitemid 37376927)
38. Lim DA, Huang Y-C, Swigut T, et al. Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature. 2009;458(7237):529-533.
39. Balasubramaniyan V, Boddeke E, Bakels R, et al. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. Neuroscience. 2006;143(4):939-951. (Pubitemid 44827521)
40. Copray S, Huynh JL, Sher F, Casaccia-Bonnefil P, Boddeke E. Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging. Glia. 2009;57(15):1579-1587.
41. Schratt G. microRNAs at the synapse. Nat Rev Neurosci. 2009;10(12):842-849.
42. Christensen M, Schratt GM. microRNA involvement in developmental and functional aspects of the nervous system and in neurological diseases. Neurosci Lett. 2009;466(2):55-62.
43. Schratt GM, Tuebing F, Nigh EA, et al. A brain-specific microRNA regulates dendritic spine development. Nature. 2006;439(7074):283-289. (Pubitemid 43128846)
44. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS. Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A. 2008;105(2):716-721. (Pubitemid 351171774)
45. Ponjavic J, Oliver PL, Lunter G, Ponting CP. Genomic and transcriptional colocalization of protein-coding and long non-coding RNA pairs in the developing brain. PLoS Genet. 2009;5(8):e1000617. doi:10.1371/journal.pgen.1000617.
46. Formisano L, Noh K-M, Miyawaki T, Mashiko T, Bennett MV, Zukin RS. Ischemic insults promote epigenetic reprogramming of μ opioid receptor expression in hippocampal neurons. Proc Natl Acad Sci U S A. 2007;104(10):4170-4175. (Pubitemid 47181597)
47. Calderone A, Jover T, Noh K-M, et al. Ischemic insults derepress the gene silencer REST in neurons destined to die. J Neurosci. 2003;23(6):2112-2121. (Pubitemid 36368899)
48. Rigamonti D, Mutti C, Zuccato C, Cattaneo E, Contini A. Turning REST/NRSF dysfunction in Huntington's disease into a pharmaceutical target. Curr Pharm Des. 2009;15(34):3958-3967.
49. Kubinová S, Syková E. Nanotechnology for treatment of stroke and spinal cord injury. Nanomedicine (Lond). 2010;5(1):99-108.
50. Modi G, Pillay V, Choonara YE, Ndesendo VMK, du Toit LC, Naidoo D. Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol. 2009;88(4):272-285.
51. Orive G, Anitua E, Pedraz JL, Emerich DF. Biomaterials for promoting brain protection, repair and regeneration. Nat Rev Neurosci. 2009;10(9):682-692.
52. Provenzale JM, Silva GA. Uses of nanoparticles for central nervous system imaging and therapy. AJNR Am J Neuroradiol. 2009;30(7):1293-1301.
53. Gao K, Huang L. Nonviral methods for siRNA delivery. Mol Pharm. 2009;6(3):651-658.
54. Weinstein JS, Varallyay CG, Dosa E, et al. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab. 2010;30(1):15-35.
55. Bédard MF, Braun D, Sukhorukov GB, Skirtach AG. Toward self-assembly of nanoparticles on polymeric microshells: near-IR release and permeability. ACS Nano. 2008;2(9):1807-1816.
56. Dalmau M, Lim S, Wang S-W. pH-triggered disassembly in a caged protein complex. Biomacromolecules. 2009;10(12):3199-3206.
57. Rao R, Nanda S. Sonophoresis: recent advancements and future trends. J Pharm Pharmacol. 2009;61(6):689-705.
58. Ellis-Behnke RG, Teather LA, Schneider GE, So K-F. Using nanotechnology to design potential therapies for CNS regeneration. Curr Pharm Des. 2007;13(24):2519-2528. (Pubitemid 47423678)
59. Bible E, Chau DYS, Alexander MR, Price J, Shakesheff KM, Modo M. The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. Biomaterials. 2009;30(16):2985-2994.
60. Park KI, Teng YD, Snyder EY. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol. 2002; 20(11):1111-1117. (Pubitemid 35285439)
61. Yamashita T, Deguchi K, Nagotani S, Kamiya T, Abe K. Gene and stem cell therapy in ischemic stroke. Cell Transplant. 2009;18(9):999-1002.
62. Yang F, Cho SW, Son SM, et al. Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci U S A. 2010;107(8):3317-3322.
63. Lutolf MP, Gilbert PM, Blau HM. Designing materials to direct stem-cell fate. Nature. 2009;462(7272):433-441.
64. Sucapane A, Cellot G, Prato M, Giugliano M, Parpura V, Ballerini L. Interactions between cultured neurons and carbon nanotubes: a nanoneuroscience vignette. J Nanoneurosci. 2009;1(1):10-16.
65. Patolsky F, Timko BP, Yu G, et al. Detection, stimulation, and inhibition of neuronal signals with high-density nanowire transistor arrays. Science. 2006;313(5790):1100-1104. (Pubitemid 44300231)